ELIS ETF Price & Analysis

Compare

ELIS ETF Chart & Stats

ETF Overview

Direxion Daily LLY Bear 1X Shares

The Direxion Daily LLY Bear 1X Shares ETF (ELIS) is a unique financial instrument designed for investors who seek to capitalize on the daily declines in the stock price of Eli Lilly and Company, a leading entity within the Pharmaceuticals niche of the Health Care sector. This ETF offers inverse (-1x) exposure, meaning it aims to deliver the opposite of Eli Lilly's daily performance, excluding fees and expenses. Ideal for short-term traders with a bearish outlook on Eli Lilly, ELIS provides a strategic tool for hedging or speculating on downward price movements within this specific pharmaceutical giant. By focusing on a single, influential stock, this fund allows investors to make targeted bets on the fluctuations of Eli Lilly's market value, making it a potent component of a diversified strategy for those interested in the dynamic and ever-evolving Health Care sector.

Direxion Daily LLY Bear 1X Shares (ELIS) Fund Flow Chart

Direxion Daily LLY Bear 1X Shares (ELIS) 1 year Net Flows: 0

ELIS ETF FAQ

What was ELIS’s price range in the past 12 months?
ELIS lowest ETF price was 25.30 and its highest was 28.79 in the past 12 months.
    What is the AUM of ELIS?
    As of Apr 04, 2025 The AUM of ELIS is 2.70M.
      Is ELIS overvalued?
      Not enough analysts have published a price target to calculate whether the price is overvalued.
      Does ELIS pay dividends?
      ELIS does not currently pay dividends.
      How many shares outstanding does ELIS have?
      Currently, no data Available
      Which hedge fund is a major shareholder of ELIS?
      Currently, no hedge funds are holding shares in ELIS
      Popular ETFs
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis